Records containing: Multiple Sclerosis, Secondary Progressive
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-09Randomized, Controlled, Open-label Study Evaluating the Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-20Intermittent Hypoxia Initiated Motor Plasticity in Individuals With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-19Motor Asymmetry in Progressive Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2026-03-11Randomized Controlled Trial of N-acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-27A Phase 1, Open-Label, Single Center Study of KYV-101, an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-23Investigating the Effects of Acute Intermittent Hypoxia on Neuroplasticity in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-23Exploring the Synergistic Effects of AIH and FES in Persons With MS
-
CLINICAL_TRIALS study record update · 2025-12-26Clinnova-MS: a Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-Regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care (Switzerland)
-
CLINICAL_TRIALS study record update · 2025-08-06A Phase 1b, Open-label Study of PIPE-791 to Determine Brain and Lung Lysophosphatidic Acid Receptor 1 (LPA1) Occupancy, by [18F] PIPE-497 PET Imaging in Healthy Volunteers, Volunteers With Progressive Multiple Sclerosis, and Volunteers With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-03-28A Multicenter Phase 1 Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis Using Orca-Q, an Engineered Donor Graft Derived From Mobilized Peripheral Blood
-
CLINICAL_TRIALS study record update · 2025-01-13KYSA-7: A Phase 2, Open-Label, Randomized, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-09-19The Effects of In-phase Bilateral Exercise on Cognitive and Motor Outcome Measures, in Patients with Progressive Multiple Sclerosis, a Randomized Control Trial.
-
CLINICAL_TRIALS study record update · 2024-07-24Development of Camera Based Gait Deviation Index for Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-06-11A Multicenter Observational Study for Ex-vivo Evaluation of the Likelihood of Response to an Experimental Tolerance Restoration Therapy in Subjects Diagnosed With Multiple Sclerosis (MS)
-
CLINICAL_TRIALS study record update · 2024-02-15Evaluating Task-Oriented Exercise Effects on Walking Function and the Central Nervous System in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-02-06Investigating the Longitudinal Relationships Between Visual Pathway Injury, Radiological and Blood Biomarkers in Multiple Sclerosis and Related Disorders
-
CLINICAL_TRIALS study record update · 2023-11-09Efficacy and Safety of OCH-NCNP1 in Patients With Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2023-09-26Novel Imaging Markers of Innate Immune Activation in Secondary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2023-07-28Safety and Efficacy of Subcutaneous Cladribine for Nonrelapsing, Secondary Progressive Multiple Sclerosis (CLASP-MS): a Randomized, Placebo-controlled, Double-blind, Phase 2 Study.
-
CLINICAL_TRIALS study record update · 2023-03-10Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-09-16Imaging of Intracerebral Inflammation in the Progressive Phase of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-05-23MUSCLE - Nordic and Free Walking in People With Multiple Sclerosis: Clinical-functional, Motor Control, and Gait Analysis Findings: a Randomized Controlled Multicentre Clinical Trials
-
CLINICAL_TRIALS study record update · 2022-05-18Open-label, Single-center, Single-arm Futility Trial Evaluating the Combination of Oral Hydroxychloroquine 200mg BID and Indapamide 2.5mg OD for Reducing Progression of Disability in People With Secondary Progressive Multiple Sclerosis (SPMS)
-
CLINICAL_TRIALS study record update · 2021-08-10Sensitivity of Quantitative Motor Performance Measures in Multiple Sclerosis - a Prospective Cohort Study Over Two Years Using Microsoft Kinect
-
CLINICAL_TRIALS study record update · 2021-04-08Cortical Lesions in the Primary Sensorimotor Hand Area and Their Impact on Dexterity in Multiple Sclerosis: a 7T MRI Study